Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection

Fertility and Sterility

Volumn 80, Issue 6, 2003, Pages 1398-1403

  Caroppo, Ettore ^a   Niederberger, Craig ^b   Vizziello, Giovanni Michele ^a   D'Amato, Giuseppe ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Inhibin B; Oligoasthenospermia; Recombinant human FSH treatment; Spermatogenesis; Testicular paracrine activity

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FERTILIZATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IDIOPATHIC OLIGOASTHENOTERAZOOSPERMIA; INTRACYTOPLASMIC SPERM INJECTION; MALE; OLIGOSPERMIA; PREGNANCY; PRIORITY JOURNAL; SEMEN ABNORMALITY; SEMEN ANALYSIS; SIDE EFFECT; SPERMATOGENESIS; TESTIS SIZE;

EID: 0346219424     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)02202-7     Document Type: Article

References (27)

1. Arnaldi G., Balercia G., Barbatelli G., Mantero F. Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia. 32:2000;155-161.
2. Baccetti B., Strehler E., Capitani S., Collodel G., De Santo M., Moretti E. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae). Hum Reprod. 12:1997;1955-1968.
3. Bartoov B., Eltes F., Lunenfeld E., Har-Even D., Lederman H., Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril. 61:1994;727-733.
4. Ben Rafael Z., Farhi J., Feldberg D., Bartoov B., Kovo M., Eltes F., et al. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization the impact on sperm microstructure and fertilization potential . Fertil Steril. 73:2000;24-30.
5. Lopes S., Guo Sun J., Jurisicova A., Meriano J., Casper R.F. Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection. Fertil Steril. 69:1998;528-532.
6. Sakkas D., Urner F., Bianchi P.G., Bizzarro D., Wagner I., Jaquenoud N., et al. Sperm chromatin anomalies can influence decondensation after intracytoplasmic sperm injection. Hum Reprod. 11:1996;837-843.
7. Sakkas D., Urner F., Bizzarro D., Manicardi G., Bianchi P.G., Shoukil Y., et al. Sperm nuclear DNA damage and altered chromatin structure effect on fertilization and embryo development . Hum Reprod. 13:1998;11-19.
8. Weinbauer G.F., Gromoll J., Simoni M., Nieschlag E. Physiology of testicular function. Nieschlag E., Behre H.M. Andrology. Male reproductive health and dysfunction. 1997;25-57 Springer-Verlag, New York.
9. Tapanainen J.S., Aittomaki K., Miu J., Vaskivuo T., Huttaniemi J.T. Men homozygous for an inactivating mutation of the follicle stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet. 15:1997;205-206.
10. Philip M., Arbelle J.E., Segev Y., Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med. 338:1998;500-501.
11. Acosta A.A., Oehninger S., Ertunc H., Philput C. Possible role of pure human follicle stimulating hormone in the treatment of severe male factor infertility by assisted reproduction preliminary report . Fertil Steril. 55:1991;1150-1156.
12. Ashkenazi J., Bar-Hava I., Farhi J., Levy T., Feldberg D., Orvieto R. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril. 72:1999;670-673.
13. Dirnfeld M., Katz G., Calderon I., Abramovici H., Bider D. Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial. Eur J Obstet Gynecol Reprod Biol. 93:2000;105-108.
14. Kamischke A., Behre H.M., Bergmann M., Simoni M., Schäfer T., Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility a randomized, double-blind, placebo-controlled, clinical trial . Hum Reprod. 13:1998;596-603.
15. Foresta C., Bettella A., Merico M., Garolla A., Ferlin A., Rossato M. Use of recombinant human follicle stimulating hormone in the treatment of male factor infertility. Fertil Steril. 77:2002;238-244.
16. In't Veld P., Brandeburg H., Verhoeff A. Sex chromosomal abnormalities and intracytoplasmic sperm injection. [letter] Lancet. 346:1995;773.
17. Bonduelle M., Aytoz A., Van Assche E., Devroey P., Liebears I., Van Steirteghem A. Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection. Hum Reprod. 13:1998;781-782.
18. Bonduelle M., Willikens J., Buysse A. Prospective study of 877 children born after intracytoplasmic injection with ejaculated, epididymal and testicular spermatozoa after replacement of cryopreserved embryos obtained after ICSI. Hum Reprod. 11:1996;131-159.
19. Chandley A.C., Hargreave T.B. Genetic anomalies and ICSI. Hum Reprod. 11:1996;930-932.
20. Stanton P.G., Robertson D.M., Burgon P.G., Schmauk-White B., Hearn M.T. Isolation and physicochemical characterization with human follicle stimulating hormone isoforms. Endocrinology. 130:1992;2820-2832.
21. Simoni M., Jockenhovel F., Nieschlag E. Polymorphism of human pituitary FSH analysis of immunoreactivity and in vitro bioactivity of different molecular species . J Endocrinol. 141:1994;359-367.
22. Foresta C., Bettella A., Merico M., Garolla A., Plebani M., Ferlin A., et al. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol. 161:2000;89-97.
23. Krishnamurthy H., Kumar K.M.P., Joshi C.V., Krishnamurthy H.N., Mougdal R.N., Sairam M.R. Alterations in sperm characteristics of follicle-stimulating hormone (FSH)-immunized men are similar to those of FSH-deprived infertile male bonnet monkeys. J Androl. 21:2000;316-327.
24. Anderson A.M., Muller J., Skakkebaek N.E. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab. 83:1998;4451-4458.
25. Foresta C., Bettella A., Petraglia E., Pistorello M., Luisi S., Rossato M. Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology. Clin Endocrinol. 50:1999;695-701.
26. Von Eckardstein S., Simoni M., Bergmann M., Weinbauer G.F., Gassner P., Schepers A.G., et al. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab. 84:1999;2496-2501.
27. Verhoven G., Franchimont P. Regulation of inhibin secretion by Sertoli cell-enriched cultures. Acta Endocrinol. 102:1983;136-143.